Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
Vercauteren K, Brown R, Mesalam A, Doerrbecker J, Bhuju S, Geffers R, Van Den Eede N, McClure C, Troise F, Verhoye L, Baumert T, Farhoudi A, Cortese R, Ball J, Leroux-Roels G, Pietschmann T, Nicosia A, Meuleman P
